Access
Email Verification
Agenda 2024 coming soon...
If you would like to be a speaker at this event, please get in touch with sean.collins@iQ-Hub.com, subject heading “Call for Papers Drug Delivery Summit 2024”.
Agenda 2023
TBC
0830 - 0930 REGISTRATION AND MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 STICKING POINT: THE IMPACT OF INNOVATION ON DRUG DELIVERY DEVICES
- Introducing patient-focused device design: more digital and convenient
- Looking at the designing success: strategic imperatives for the industry
- Getting real with environmental sustainability
Aaron Wright
IQVIA
IQVIA
1010 - 1030 SPEED NETWORKING SESSION
- Exchange business cards and get connected in short one-to-one meetings
- Start the conversation to arrange a more formal meeting later on in the conference
- Share your professional background and discuss your biggest business issues - Don't forget your business cards!
Conference Host
1030 - 1100 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1100 - 1130 LIPID–COMPOSITE MICROSYSTEMS FROM EXPANDING, LIQUID-CO₂ TECHNOLOGY
- Expanding liquid CO₂ as congealing, atomizing and drying agent
- Looking at lipid-composite microspheres to control and improve drug performance
- Understand the advantages of oral and topical drug delivery
Pierandrea Esposito
SITEC pharmabio
SITEC pharmabio
1130 - 1200 DELIVERY OF BIOLOGICS TO THE NASAL CAVITY: FORMULATION STRATEGIES
- Understand challenges and opportunities for the delivery of biologics to the nasal cavity
- Know more about formulation strategies to successfully deliver biomolecules to the nose
- Learn combination formulation/device and tools for assessment of regional deposition
Irene Rossi
Nanopharm
Nanopharm
1200 - 1330 NETWORKING LUNCH & VISIT THE DRUG DELIVERY EXHIBITION
1330 - 1400 OPPORTUNITIES IN ENABLING PERSONALISED THERAPIES FOR BRAIN DISORDERS
- Looking at the exosome-based drug delivery for brain disorders
- Challenges in developing personalised therapies for brain disorders
- Latest advancements in exosome-based engineering and its potential for targeted delivery
Luis Valente
iLoF
iLoF
1400 - 1430 NEW DRUG DELIVERY TECHNOLOGY TO INCREASE EFFICACY AND PATIENT CONVENIENCE
- Making substitution of injection to pain-free application
- Predicting the increase of bioavailability by circumventing the 1st pass metabolism
Emrah Yildir
AdhexPharma
AdhexPharma
1430 - 1500 EVOLUTION OF A (P)REFILLABLE DPI
- Initial development of a high payload blister-based reusable/refillable single-dose device
- High-performance delivery engine and optimisation using computational fluid dynamics
- Potential to use the device in future products, e.g. biologics and acute use applications
Phil Swanbury
Vectura
Vectura
1500 - 1530 AFTERNOON COFFEE BREAK IN THE EXHIBIT AREA
1530 - 1600 LIQUID ORAL CONTROLLED RELEASE TECHNOLOGY – PARADIGM SHIFT
- Understanding the need for liquid oral control release formulation
- Looking at the grey areas and opportunity to develop new technology
- A look ahead – in oral liquid controlled release technology and the path forward
Ankit Baheti
Ferring Pharmaceuticals
Ferring Pharmaceuticals
1600 - 1630 CHALLENGES IN DESIGNING NEXT-GEN DRY POWDER INHALERS
- Learn different approaches for sustainable development of generic DPI
- Understand the role of connectivity in improving adherence
- Know more about why adherence is so poor in respiratory diseases
Marco Franza
Berry Global
Berry Global
1630 - 1700 SONOPHORESIS SMART PATCH FOR NEEDLE-FREE TRANSDERMAL DELIVERY
- Learn about non-invasive delivery device based on a combination of ultrasound waves
- Introducing a miniaturized ultrasound generator
- Potential drug delivery platform with easy adaptation
Eduardo Jørgensen
Medicsen
Medicsen
1700 - 1800 NETWORKING DRINKS RECEPTION
TBC
0900 - 0930 MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 PATIENT ENGAGEMENT AND DEI ACROSS THE DRUG DELIVERY CONTINUUM
- Looking at the current global DEI guidelines and regulations
- Learn how to build and implement a data-driven DEI program
- A look ahead – in the space of patient engagement in 2024 and beyond
Kayt Leonard
SAS
SAS
1010 - 1040 BIO-ELECTRONIC CELL-BASED IMPLANT FOR MULTIPLE SCLEROSIS TREATMENT
- Printed technologies as key enabling technologies for healthcare devices
- Understand optogenetics techniques to control and monitor the activities of cells in a living tissue
- Introducing a multifunctional platform to revolutionise the therapeutic protein delivery
Alejandra Ben Aissa Soler
Eurecat
Eurecat
1040 - 1110 PHARMACEUTICAL APPLICATIONS OF NUTRACEUTICALS AND CANNABINOIDS
- Emerging formulation technologies for addressing severe malabsorption
- Safety and efficacy considerations associated with compliance and long-term
- Formulation for product dosage forms and site of application
Andreas Papas
Antares Health Products
Antares Health Products
1110 - 1130 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1130 - 1200 IMPROVING IVIVCS OF OINDPS: BRIDGING THE GAP BETWEEN THE HUMAN RESPIRATORY SYSTEM AND IN-VITRO MODEL
- Why are IVIVCs a challenge for OINDPs?
- Current regulatory guidance
- Moving towards better IVIVCs: realistic breathing profiles
- Moving towards better IVIVCs: realistic throat and nasal models
Clair Brooks
Copley Scientific
Copley Scientific
1200 - 1230 OLEOGELS FOR THE NOSE-TO-BRAIN DELIVERY OF OLIGONUCLEOTIDES
- Looking at the advantages of nasal administration of therapeutics
- Developing a mucoadhesive oleogel delivering the drug to the brain by avoiding the blood-brain barrier
- Demonstrating a slowed/protected release when compared to naked ASO
Vivek Trivedi
University of Kent
University of Kent
1230 - 1300 OPTIMISATION OF FORMULATION SELECTION AND CONTINUOUS MANUFACTURING
- Introducing a thermodynamic approach for conscious excipient selection
- Novel integrity test methods for modular, continuous biopharmaceuticals manufacturing
Ildiko Terebesi
INVITE Research
INVITE Research
1300 - 1315 FEEDBACK & RAFFLE DRAW
1315 - 1430 NETWORKING LUNCH
Quick Proposal
Key topics for 2024:
- Formulation design for poorly soluble compounds
Understand the most recent technological advancements to improve the dissolution and bioavailability of poorly soluble drugs. - New drug delivery technologies for better deliverability
The future of drug deliveries across the skin barrier to the systemic circulation via Iontophoresis, electroporation, sonophoresis, magnetophoresis, dermal patches,nanocarriers, and needled and needle-less shots. - Latest developments in controlled released technologies
Evaluate controlled release methods that enhance drug therapy's safety, efficacy, reliability, and convenience by controlling the rate and duration of drug release to control drug actions. - Optimizing drug formulations for continuous manufacturing
Learn about new methods in continuous manufacturing for the pharmaceutical industry, which offers the potential for cost reduction, enhanced efficiency, and economic viability. - Overcoming the blood-brain barrier and re-engineering biologics
Looking at the structural elements and anatomical features of the blood-brain barrier, various in vivo, in situ blood-brain barrier models, and adopting molecular Trojan horse technologies. - Developing new drug modalities and biotherapeutics
Achieve a deeper understanding of biotherapeutics and novel drug modalities beyond traditional small molecules, including RNA-based approaches, targeted protein degradation, covalent inhibitors, next-generation peptides, and antibodies.
Sponsorship Opportunities
Join us as a sponsor for this IQ International conference! Reach your target audience, limit competitor influence at the conference and become a keynote speaker, while sharing your company's solutions for this industry.
- Get registration discounts
- Enhance your brand awareness
- Additional marketing opportunities